Has the Robot Made Cholecystectomy Safer? Bile Duct Injury, Minilaparoscopy, and the Enduring Lesson of Training and...

Bile duct injury is the most feared complication of cholecystectomy: more common than high-income registries suggest, catastrophic and lasting. The robot did not invent this danger; it revived an old one. Its adoption is outpacing any proof that it protects the common bile duct. The deeper question is what that signal teaches about what protects patients when a new platform enters the operating room.

A narrative synthesis of the comparative evidence, the randomized and registry data on minilaparoscopy, and the preclinical work on surgical autonomy. Every pooled event count was checked against its primary source, with Poisson CIs and a leave-one-out sensitivity analysis.

More than a million patients, in national files and an independent registry, point one way: robotic cholecystectomy carries a reproducible excess of bile duct injury over laparoscopy. It survives the analysis built to strip away case selection (instrumental-variable relative risk: 1.88; 95% CI: 1.14-2.63), holds across every risk stratum, and the robot's injury rate in its easiest patients exceeds laparoscopy's in its hardest. In contemporary practice, it narrowed but did not close. The robot does well away from the duct, converting to open surgery less than half as often. The fault is not the machine. Its advantages in ergonomics, vision, and precision are the trap. It has become the beginner's operation; its learning curve runs long (87% of surgeons are still inside it), and it removes the tactile feedback that once checked a careless pull. Overconfidence is easy to suspect and hard to prove: only 8% of the most-watched online videos showed an adequate Critical View of Safety (CVS), and fluorescence identifies the duct without preventing injury. What guards the duct is not the platform but training and discipline: the CVS earned, the judgment to abandon it when the anatomy refuses, and the timely bail-out. Minilaparoscopy proves the point: it reports 0.018% across 16,272 verified cases, an enthusiast-reported literature not directly comparable with administrative cohorts, and randomized trials show small ports earn no protective credit. The discipline, not the millimeters, does the work.

This is no verdict against robotics. Safety has always lived in training and discipline, never in the instrument, and any platform that loosens them is punished at the bile duct. Minilaparoscopy earns its place because it compels that discipline. Autonomous systems, trained so far only on anatomically ordinary gallbladders, inherit the same demand. The platform keeps changing. The lesson does not.